Order Gardasil® 9 (Slovakian) for Clinics

Gardasil® 9 (Slovakian) is a Human papillomavirus 9-valent vaccine used in preventive immunization programs for licensed clinics and healthcare professionals. Clinics can order Gardasil 9 vaccine for professional administration within established vaccine protocols, with lot and expiration information supporting EHR and registry documentation. This Slovak-language packaging variant may be useful for facilities that need localized manufacturer materials for internal records or staff workflows.

Gardasil 9 is administered by intramuscular injection and is intended to help prevent disease caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. It is preventive, not therapeutic, so it does not treat existing HPV infection, HPV-related lesions, or cancer. Cervical cancer screening and other professional follow-up should continue according to applicable clinical guidance.

Gardasil 9 Price, Clinic Ordering, and Product Selection

Current prices and quantity breaks are shown on this page, and licensed clinics can order as a guest or with an account. For formulary planning beyond this vaccine, the Pharmaceuticals category can help purchasing teams review adjacent regulated medical products.

When preparing a purchase order, match the product name, language variant, quantity, and SKU used by your inventory team. Current content identifies SKU 89601 for ordering traceability. Because vaccine workflows depend on accurate records, receiving teams should reconcile outer carton information, lot number, expiration date, and any internal inventory code before moving units into clinical stock.

Gardasil 9 searches often include dose volume terms such as 0.5 mL or prefilled syringe wording, but clinic ordering should follow the presentation shown during checkout and the manufacturer materials received with the unit. Do not substitute a packaging variant, schedule, or administration process without medical director approval and updated standing orders. If your facility uses multilingual documentation, the Slovakian presentation can support that operational preference while maintaining product identity as Gardasil 9.

Professional Use and HPV Prevention Context

Gardasil 9 is used in preventive immunization programs for adolescents and adults within the authorized age range. Current authoritative information describes use in females and males from age 9, with U.S. labeling commonly covering individuals through 45 years of age. Clinics should verify the current package insert and local protocol before vaccination, especially when standing orders include catch-up vaccination or adult immunization sessions.

The vaccine targets nine HPV types. Types 6 and 11 are commonly associated with genital warts, while types 16, 18, 31, 33, 45, 52, and 58 are associated with high-risk HPV-related lesions and cancers. The product is designed to generate an immune response before exposure to the covered HPV types. It should not be positioned as treatment for active HPV infection, abnormal screening results, existing genital warts, or diagnosed HPV-related disease.

Gynecology services, family medicine practices, primary care groups, campus health centers, and public health teams often integrate HPV vaccination into preventive visits. For clinics coordinating vaccination with reproductive health or women’s health workflows, the Gynecology category may support broader program planning. Intake, consent, registry entry, vaccine administration, and post-vaccination observation should remain consistent with clinic policy.

Composition, Antigen Coverage, and Mechanism

Gardasil 9 is a recombinant 9-valent HPV vaccine. The active antigen components correspond to HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. These are non-replicating protein-based components in a sterile suspension formulated for intramuscular use.

The vaccine works by prompting the immune system to produce antibodies against the listed HPV types. In practical clinic terms, that means the product is scheduled before exposure whenever possible and documented as part of a series-based prevention program. It does not contain live HPV and cannot cause HPV infection from vaccination.

Programs should use official dosing guidance for two-dose or three-dose schedules, depending on patient age at initiation and applicable clinical circumstances. Staff should avoid creating informal schedule shortcuts during high-volume clinics. Missed or delayed doses should be handled according to professional guidance and clinic protocol rather than restarting or changing the series without review.

Key Features for Clinic Inventory

• Human papillomavirus 9-valent vaccine covering HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58.
• Intramuscular administration that fits standard vaccine injection workflows.
• Preventive immunization product, not treatment for existing HPV infection or disease.
• Series-based use under official guidance and standing orders.
• Slovak-language packaging variant for facilities with localized documentation needs.
• Manufacturer lot and expiration details support registry reporting and reconciliation.
• Suitable for professional immunization settings such as gynecology, primary care, campus health, and public health clinics.
• SKU 89601 supports internal purchasing and inventory traceability.

Quick tip: Keep the language variant, lot number, and expiration date visible in receiving records before units are assigned to clinic stock.

Storage, Handling, and Receiving Workflow

Vaccines require careful receiving and storage practices. Gardasil 9 should be handled according to the current package insert and your facility’s vaccine storage SOPs. Receiving staff should inspect the manufacturer packaging, record lot and expiration information, and escalate any temperature excursion or packaging concern through the clinic’s vaccine management process.

Use temperature-controlled handling when required and tracked US delivery for logistics planning. This statement does not replace manufacturer storage instructions or your internal cold-chain documentation. Facilities should ensure refrigerators, data loggers, quarantine procedures, and staff responsibilities are defined before scheduling large immunization events.

During clinic sessions, teams should maintain clear separation between vaccine inventory, ancillary supplies, sharps disposal, consent forms, and documentation tools. Standardizing these steps reduces avoidable errors, especially when multiple vaccines are administered during the same outreach day. If Gardasil 9 is used alongside other immunizations, keep product-specific consent, administration site, lot, and series information distinct in the EHR and immunization registry.

Safety, Contraindications, and Monitoring

Gardasil 9 should be used under professional vaccine protocols that include screening for contraindications and precautions. Serious allergic reaction to a previous dose or to a vaccine component is a key contraindication described in official labeling. Clinics should review the current package insert for the full ingredient list and safety information before administration.

Commonly reported reactions with HPV vaccination can include injection-site pain, swelling, redness, headache, fever, nausea, dizziness, and fatigue. Syncope can occur after vaccination, particularly in adolescents, so observation procedures and fall-prevention measures should be part of clinic workflow. Staff should be ready to manage immediate hypersensitivity reactions according to emergency protocols.

Pregnancy, acute illness, immunocompromising conditions, and prior HPV-related disease may require clinician review before vaccination or schedule planning. Gardasil 9 does not eliminate the need for cervical cancer screening because it does not protect against every oncogenic HPV type and does not treat infection acquired before vaccination. Documentation should reflect screening questions, consent, product administered, site, route, lot, expiration, and any post-vaccination observation notes required by your protocol.

Slovakian Packaging and European Use Questions

Gardasil 9 is used in Europe, and European regulatory sources describe Gardasil 9 as a vaccine for males and females from age nine to protect against conditions caused by nine HPV types. A Slovakian packaging variant means the outer carton and leaflet materials may include Slovak-language text and region-specific presentation details. It does not change the need to follow the manufacturer materials supplied with the unit and your facility’s approved protocol.

Some clinics ask whether Gardasil was discontinued. Earlier HPV vaccine formulations, including quadrivalent versions, have changed market status over time in some regions as 9-valent products became standard. That does not mean Gardasil 9 is discontinued. Gardasil 9 remains the current 9-valent HPV vaccine referenced by major regulatory and manufacturer sources.

Clinics may also receive patient questions about how common HPV is or whether protection lasts a lifetime. HPV is widely recognized as a common sexually transmitted infection, and vaccination programs are designed to reduce risk from covered HPV types before exposure. Duration of protection, booster policy, and individual counseling should be addressed using current public health guidance and clinician judgment.

Benefits in Practice

Standardizing on a 9-valent HPV vaccine can simplify clinic operations. A single vaccine line can serve routine adolescent programs, catch-up vaccination, and adult immunization appointments when patients fall within the authorized age range and meet clinical criteria. This supports consistent staff training, consent language, EHR build, inventory planning, and registry reporting.

Broad HPV type coverage also helps programs communicate clearly with patients and caregivers. Staff can explain that the vaccine is intended to help prevent disease associated with nine HPV types while avoiding overstated claims. The most useful counseling points are practical: it is preventive, it is given as a series, it does not treat existing infection, and screening recommendations still apply.

For purchasing teams, the Slovakian presentation may provide a specific documentation match for multilingual facilities or internal training materials. For clinical teams, the core workflow remains the same: maintain proper storage, screen before administration, document carefully, observe according to protocol, and report adverse events as required.

Comparable and Adjacent Products

Gardasil 9 is not interchangeable with every vaccine in a clinic refrigerator. It has a specific HPV prevention role and a defined antigen profile. When clinics plan multi-vaccine sessions, each product should have its own storage requirements, consent language, administration documentation, and schedule logic.

Adjacent formulary planning may include gynecology-related products, preventive-care supplies, and other regulated medical products used in clinic programs. Keep HPV vaccination decisions separate from contraceptive counseling, cervical screening follow-up, and treatment of active lesions. Those workflows may overlap operationally, but they serve different clinical purposes.

When evaluating alternatives or historical HPV vaccine names, compare antigen coverage, labeled age range, regional labeling, and current protocol status. Gardasil 4 versus Gardasil 9 questions usually concern the difference between quadrivalent and 9-valent coverage. Medical directors should define which product is acceptable in standing orders and how prior doses from another HPV vaccine series are documented.

Authoritative Sources

• FDA Gardasil 9 information
• CDC HPV vaccine information
• European Medicines Agency Gardasil 9 record

Ready to order? Choose your quantity above, or call 1-800-630-9757 to talk to our customer service team.

This content is for informational purposes only and is not a substitute for professional medical advice.